MitotaneAlternative Names: Lisodren; Lysodren
Latest Information Update: 20 Aug 2015
At a glance
- Originator Bristol-Myers Squibb
- Developer Bristol-Myers Squibb; HRA Pharma
- Class Antineoplastics; Chlorinated hydrocarbons; Small molecules
- Mechanism of Action Hormone inhibitors; Steroid receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Adrenocortical carcinoma
Most Recent Events
- 15 Mar 2016 Biomarkers information updated